...
首页> 外文期刊>Science >Disparate Individual Fates Compose Robust CD8~+ T Cell Immunity
【24h】

Disparate Individual Fates Compose Robust CD8~+ T Cell Immunity

机译:不同的个体命运组成了强大的CD8〜+ T细胞免疫力

获取原文
获取原文并翻译 | 示例
           

摘要

A core feature of protective T cell responses to infection is the robust expansion and diversification of naieve antigen-specific T cell populations into short-lived effector and long-lived memory subsets. By means of in vivo fate mapping, we found a striking variability of immune responses derived from individual CD8~+ T cells and show that robust acute and recall immunity requires the initial recruitment of multiple precursors. Unbiased mathematical modeling identifies the random integration of multiple differentiation and division events as the driving force behind this variability. Within this probabilistic framework, cell fate is specified along a linear developmental path that progresses from slowly proliferating long-lived to rapidly expanding short-lived subsets. These data provide insights into how complex biological systems implement stochastic processes to guarantee robust outcomes.
机译:保护性T细胞对感染的反应的一个核心特征是,将幼稚的抗原特异性T细胞群体稳健地扩展和多样化,变成了短寿命的效应子和长寿命的记忆子集。通过体内命运图谱,我们发现了来自单个CD8〜+ T细胞的免疫反应的惊人变化,并表明强大的急性和召回免疫力需要多种前体的初始募集。无偏数学建模将多个微分和除法事件的随机积分确定为这种可变性的驱动力。在此概率框架内,细胞命运沿线性发展路径指定,该路径从缓慢增殖的长寿命子集发展到迅速膨胀的短寿命子集。这些数据提供了有关复杂生物系统如何执行随机过程以确保可靠结果的见解。

著录项

  • 来源
    《Science》 |2013年第6132期|630-635|共6页
  • 作者单位

    Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen (TUM), Munich 81675, Germany;

    Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,BioQuant Center, University of Heidelberg, Heidelberg 69120, Germany;

    Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen (TUM), Munich 81675, Germany;

    Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen (TUM), Munich 81675, Germany;

    Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen (TUM), Munich 81675, Germany;

    Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen (TUM), Munich 81675, Germany;

    Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen (TUM), Munich 81675, Germany;

    Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen (TUM), Munich 81675, Germany,Clinical Cooperation Groups "Antigen-specific Immunotherapy" and "Immune-Monitoring," Helmholtz Center Munich (Neuherberg), TUM, Munich 81675, Germany;

    Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,BioQuant Center, University of Heidelberg, Heidelberg 69120, Germany;

    Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen (TUM), Munich 81675, Germany,Clinical Cooperation Groups "Antigen-specific Immunotherapy" and "Immune-Monitoring," Helmholtz Center Munich (Neuherberg), TUM, Munich 81675, Germany,Focus Group "Clinical Cell Processing and Purification," Institute for Advanced Study, TUM, Munich 81675, Germany,National Centre for Infection Research (DZIF), Munich 81675, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号